SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Arrowhead Resarch
An SI Board Since October 2004
Posts SubjectMarks Bans Symbol
172 20 0 ARWR
Emcee:  mikehunt2 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
97Calando Pharmaceuticals Announces Completion of IT-101 Phase 1 Clinical Study Thmikehunt2-10/23/2008
96Arrowhead CEO Provides Update on Majority Owned Subsidiary Calando Pharmaceuticamikehunt2-10/21/2008
95more uses for their technolgy cosmos.bcst.yahoo.commikehunt2-10/20/2008
94Unidym Announces a Demonstration by Samsung Electronics of the First Color Carbomikehunt2-10/16/2008
93Arrowhead CEO Updates Stockholders Tuesday October 14, 7:00 am ET PASADENA, Camikehunt2-10/14/2008
92Calando Pharmaceuticals Announces Next siRNA Therapeutic Candidate for Oncology mikehunt2-9/15/2008
91Calando Pharmaceuticals Phase II Clinical Study Opens to Patient Enrollment Thurmikehunt2-9/11/2008
90Unidym Enters into Second Joint Development Agreement with Samsung Electronics tmikehunt2-8/12/2008
89Item 8.01. Other Events. The Company is filing this Current Report on Form 8mikehunt2-7/14/2008
88Arrowhead Forms New Subsidiary to Commercialize Energy Storage Devices Wednesdaymikehunt2-7/9/2008
87Unidym Inc. Announces Launch of Patent License Option Program and Execution of Fmikehunt2-6/30/2008
86Calando Pharmaceuticals Collaborates with City of Hope to Initiate Investigator mikehunt2-6/12/2008
85Calando Pharmaceuticals Doses First Patient in siRNA Phase I Clinical Trial Mondmikehunt2-6/2/2008
84Unidym Demonstrates First Full Color Active Matrix LCD Using a Carbon Nanotube-Bmikehunt2-5/20/2008
83Unidym Announces a Demonstration by Samsung Electronics of the First Carbon Nanomikehunt2-5/20/2008
82Calando Pharmaceuticals of Pasadena, CA, received a China patent for broad covermikehunt2-5/20/2008
81Calando Granted Broad Patent Rights to RNAi Technology in China Tuesday May 13, mikehunt2-5/13/2008
80Nanotube Alignment genengnews.com >> Apr 23 2008, 1:06 PM EST Nanotubemikehunt2-4/24/2008
79Arrowhead Nanobiotechnology Subsidiaries, Calando Pharmaceuticals and Insert Themikehunt2-4/24/2008
78Unidym Inc. Announces the First Flight of an Aircraft Using Carbon Nanotubes formikehunt2-4/22/2008
77Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA mikehunt2-4/21/2008
76Insert Therapeutics to Initiate a Multinational Phase II Clinical Trial of Lead mikehunt2-4/17/2008
75this could be huge cityofhope.org W. M. Keck Foundation awards grant to continmikehunt2-4/4/2008
74Unidym Inc. Spins off Ensysce Biosciences Inc. to Pursue Medical Therapeutic Appmikehunt2-3/18/2008
73Arrowhead CEO Presents 2008 Objectives Friday March 14, 3:19 am ET PASADENA, Cmikehunt2-3/14/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News